SCHEMBL30327240

SCHEMBL30327240

Clc1ccc(-c2cnc3cn[nH]c3c2)cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.48
PDGFRA P16234 1/20 0.48
DYRK1A Q13627 3/20 0.46
FGFR1 P11362 3/20 0.45
AHR P35869 2/20 0.45
NOTUM Q6P988 1/20 0.44
CLK4 Q9HAZ1 3/20 0.42
PRKD3 O94806 2/20 0.42
MAP4K4 O95819 2/20 0.42
FLT3 P36888 2/20 0.42
MAPK9 P45984 2/20 0.42
CSNK1A1 P48729 2/20 0.42
GSK3B P49841 2/20 0.42
MINK1 Q8N4C8 2/20 0.42
SLK Q9H2G2 2/20 0.42
MAP4K5 Q9Y4K4 2/20 0.42
DCLK1 O15075 1/20 0.42
EGFR P00533 1/20 0.42
PRKACA P17612 1/20 0.42
FRK P42685 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30133051 0.86 RAF1 (0.47) DYRK1AFGFR1CLK4PRKD3MAP4K4
SCHEMBL29901487 0.84 GRIN2B (0.46) DYRK1AFGFR1CLK4PRKD3MAP4K4
SCHEMBL29901465 0.81 GRIN2B (0.53) DYRK1AFGFR1NOTUMGRIN1GRIN2B
SCHEMBL29525178 0.80 GRIN2B (0.56) GRIN1GRIN2B
SCHEMBL22771400 0.80 GRIN2B (0.56) GRIN1GRIN2B
SCHEMBL30326991 0.79 FGFR1 (0.48) DYRK1AFGFR1NOTUMMAP4K4GRIN1
SCHEMBL17754955 0.78 DYRK1A (0.50) PDGFRBPDGFRADYRK1AFGFR1CLK4
SCHEMBL30133030 0.77 PDGFRB (0.48) PDGFRBPDGFRADYRK1AFGFR1NOTUM
SCHEMBL17754954 0.77 DYRK1A (0.49) PDGFRBPDGFRADYRK1AFGFR1CLK4
SCHEMBL29525098 0.77 DYRK1A (0.49) PDGFRBPDGFRADYRK1AFGFR1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250136598-A1 SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2025-05-01 US disclosed
US-12172997-B2 Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2024-12-24 US disclosed
US-20230151006-A1 SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2023-05-18 US disclosed
US-11618750-B2 Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2023-04-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12172997-B2 Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators GRIN2B, GRIN2A, GRIN3A PDGFRB 87/4885PDGFRA 146/4885DYRK1A 2657/4885
US-20230151006-A1 SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR GRIN2B, GRIN2A, GRIN3A PDGFRB 85/4885PDGFRA 141/4885DYRK1A 2728/4885
US-20250136598-A1 SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS GRIN2B, GRIN2A, GRIN3A PDGFRB 87/4885PDGFRA 146/4885DYRK1A 2657/4885
US-11618750-B2 Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators GRIN2B, GRIN2A, GRIN3A PDGFRB 87/4885PDGFRA 146/4885DYRK1A 2657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.